Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pharmacokinetics of Multiple-Dose Levofloxacin in Hemodialysis Patients  Shuichi Tsuruoka, MD, PhD, Noritsugu Yokota, MD, PhD, Tokie Hayasaka, RN, Tetsuo.

Similar presentations


Presentation on theme: "Pharmacokinetics of Multiple-Dose Levofloxacin in Hemodialysis Patients  Shuichi Tsuruoka, MD, PhD, Noritsugu Yokota, MD, PhD, Tokie Hayasaka, RN, Tetsuo."— Presentation transcript:

1 Pharmacokinetics of Multiple-Dose Levofloxacin in Hemodialysis Patients 
Shuichi Tsuruoka, MD, PhD, Noritsugu Yokota, MD, PhD, Tokie Hayasaka, RN, Tetsuo Saito, MD, PhD, Kunihiro Yamagata, MD, PhD  American Journal of Kidney Diseases  Volume 58, Issue 3, Pages (September 2011) DOI: /j.ajkd Copyright © 2011 National Kidney Foundation, Inc. Terms and Conditions

2 Figure 1 Profile of plasma levofloxacin concentration during and after a hemodialysis (HD) session. Patients used 500 mg of the drug after HD on the first day and 250 mg 4 hours before HD on the third day. Blood sampling was performed just before and 2 and 4 hours after HD. Another sampling was performed just before the next HD session (44 hours after the end of the previous session). American Journal of Kidney Diseases  , DOI: ( /j.ajkd ) Copyright © 2011 National Kidney Foundation, Inc. Terms and Conditions


Download ppt "Pharmacokinetics of Multiple-Dose Levofloxacin in Hemodialysis Patients  Shuichi Tsuruoka, MD, PhD, Noritsugu Yokota, MD, PhD, Tokie Hayasaka, RN, Tetsuo."

Similar presentations


Ads by Google